4EL0 image
Deposition Date 2012-04-10
Release Date 2012-07-25
Last Version Date 2023-12-06
Entry Detail
PDB ID:
4EL0
Keywords:
Title:
Crystal structure of GPb in complex with DK16
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.21
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Glycogen phosphorylase, muscle form
Gene (Uniprot):PYGM
Chain IDs:A
Chain Length:825
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
LLP A LYS ?
Ligand Molecules
Primary Citation
The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: Synthesis, biochemical and biological assessment.
Eur.J.Med.Chem. 54 740 749 (2012)
PMID: 22770609 DOI: 10.1016/j.ejmech.2012.06.029

Abstact

C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides have been synthesized and studied as inhibitors of glycogen phosphorylase b (GPb). Kinetic experiments have shown that most of these compounds were low micromolar inhibitors of the enzyme. The best inhibitor was 1-(β-D-glucopyranosyl)-5-ethynyluracil (K(i)=4.7 μM). Crystallographic analysis of these compounds in complex with GPb revealed that inhibitors with a long C5-alkynyl group exploited interactions with β-pocket of the active site and induced significant conformational changes of the 280s loop compared to GPb in complex with compounds with a short C5-alkynyl group. The results highlight the importance in the length of the aliphatic groups used to enhance inhibitory potency for the exploitation of the hydrophobic β-pocket. The best of the inhibitors had also a moderate effect on glycogenolysis in the cellular lever with an IC(50) value of 291.4 μM.

Legend

Protein

Chemical

Disease

Primary Citation of related structures